Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-252375
Filing Date
2019-09-24
Accepted
2019-09-24 08:57:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d803787dsc13d.htm SC 13D 43836
  Complete submission text file 0001193125-19-252375.txt   45274
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Subject) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91134 | Film No.: 191109318
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLAREDON STREET BOSTON MA 02116 6175162000
BC SW, LP (Filed by) CIK: 0001786351 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D